SENSE makes us rethink the second-generation nonnucleoside reverse transcriptase inhibitor etravirine's place in HIV-1 treatment.
Jade
J
Ghosn
D019380:Anti-HIV Agents; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000009:adverse effects*; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; C451734:etravirine